Up-down regulation of HIF-1α in cancer progression

M Rashid, LR Zadeh, B Baradaran, O Molavi… - Gene, 2021 - Elsevier
Hypoxia induicible factor-1 alpha (HIF-1α) is a key transcription factor in cancer progression
and target therapy in cancer. HIF-1α acts differently depending on presence or absence of …

Therapeutic strategies to overcome taxane resistance in cancer

T Das, U Anand, SK Pandey, CR Ashby Jr… - Drug Resistance …, 2021 - Elsevier
One of the primary causes of attenuated or loss of efficacy of cancer chemotherapy is the
emergence of multidrug resistance (MDR). Numerous studies have been published …

[HTML][HTML] HIF-1α pathway: role, regulation and intervention for cancer therapy

GN Masoud, W Li - Acta Pharmaceutica Sinica B, 2015 - Elsevier
Abstract Hypoxia-inducible factor-1 (HIF-1) has been recognized as an important cancer
drug target. Many recent studies have provided convincing evidences of strong correlation …

[HTML][HTML] Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer

C Wigerup, S Påhlman, D Bexell - Pharmacology & therapeutics, 2016 - Elsevier
Insufficient tissue oxygenation, or hypoxia, contributes to tumor aggressiveness and has a
profound impact on clinical outcomes in cancer patients. At decreased oxygen tensions …

[HTML][HTML] Role of metabolism in cancer cell radioresistance and radiosensitization methods

L Tang, F Wei, Y Wu, Y He, L Shi, F Xiong… - Journal of Experimental …, 2018 - Springer
Background Radioresistance is a major factor leading to the failure of radiotherapy and poor
prognosis in tumor patients. Following the application of radiotherapy, the activity of various …

[HTML][HTML] Hypoxia-inducible factors: cancer progression and clinical translation

EE Wicks, GL Semenza - The Journal of clinical …, 2022 - Am Soc Clin Investig
Hypoxia-inducible factors (HIFs) are master regulators of oxygen homeostasis that match O2
supply and demand for each of the 50 trillion cells in the adult human body. Cancer cells co …

Pharmacologic targeting of hypoxia-inducible factors

GL Semenza - Annual review of pharmacology and toxicology, 2019 - annualreviews.org
Hypoxia-inducible factors (HIFs) control transcriptional responses to reduced O2 availability.
HIFs are heterodimeric proteins composed of an O2-regulated HIF-α subunit and a …

[HTML][HTML] Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics

J Zhang, Z Hu, CA Horta, J Yang - Seminars in cancer biology, 2023 - Elsevier
Epithelial–mesenchymal transition (EMT) has been implicated in various aspects of tumor
development, including tumor invasion and metastasis, cancer stemness, and therapy …

Placenta: the forgotten organ

E Maltepe, SJ Fisher - Annual review of cell and developmental …, 2015 - annualreviews.org
The placenta sits at the interface between the maternal and fetal vascular beds where it
mediates nutrient and waste exchange to enable in utero existence. Placental cells …

[HTML][HTML] Microtubule targeting agents in disease: classic drugs, novel roles

L Wordeman, JJ Vicente - Cancers, 2021 - mdpi.com
Simple Summary Microtubules (MTs) are highly conserved proteins present in all eukaryotic
organisms. They form the cell cytoskeleton, and its function is essential for a large number of …